Commercial Medical Devices

UK confirms long-term CE mark recognition for medical devices

The decision keeps EU-approved devices eligible for the Great Britain market while the UKCA route remains in place.

Samira HaleOctober 22, 20265 min read10 views
A conceptual clinical still life of medical devices arranged along a continuous pathway, suggesting regulatory continuity and stable patient access.

The UK government has confirmed that CE-marked medical devices and in vitro diagnostic devices will continue to be accepted in Great Britain on a long-term basis. The decision means patients will retain access to products ranging from insulin pumps and replacement joints to diagnostic tests and surgical equipment.

The confirmation followed a public consultation that ran from 16 February to 10 April 2026 and drew more than 1,000 responses from patients, healthcare organisations, industry and other stakeholders.

No duplicate approval route

Under the confirmed approach, devices already approved for the European market will not need an additional UK approval route. The government said this avoids duplication for manufacturers and helps maintain stable supply and patient access to medical technologies.

More than 90% of medical devices currently registered for use in Great Britain carry a CE mark. That mark indicates the devices have been assessed and approved for the European market, and recognition of that approval provides access to the Great British market.

UKCA route continues

The CE recognition sits alongside the UKCA marking route, which continues to operate as the domestic approval pathway for devices placed on the market in Great Britain. Guidance remains available on placing UKCA- or CE-marked products on the GB market.

The government framed the decision as a way to maintain safe, uninterrupted access to treatments and technologies used by patients and the NHS. It also reduces the need for manufacturers of EU-approved devices to pursue a separate Great Britain approval process.